PARSIPPANY, NJ--(Marketwired - Jan 14, 2015) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior experts of Ogilvy & Mather (www.ogilvy.com), announced the agency has been recognized as the Silver winner in the DTC/DTP category of the 2014 PM360 Pharma Choice Awards for their work created to support a medication used to treat multiple sclerosis. 

Ogilvy CommonHealth Worldwide is a WPP company (NASDAQ: WPPGY) (www.wpp.com). The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.

Now in its 6^th year and presented by PM360, a health-marketing industry trade magazine, the Pharma Choice Awards, recognize the best healthcare creative campaigns and initiatives in 12 categories: Professional Campaign, Consumer and Professional Websites, Unbranded, Sales Aid, App, Print and Digital Self-Promotion, Video, DTC/DTP, Multichannel and Other. The winners are featured in the January 2015 issue of PM360.

Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. Our global headquarters are in Parsippany, NJ, with additional North American offices in Irvine, CA, Newtown, CT, Chapel Hill, NC, New York, NY and Toronto and Montreal, Canada. With 56 offices in 39 cities across 32 markets, our offices are located in key geographies aligned with healthcare's global footprint. Ogilvy CommonHealth Worldwide provides marketing services including behavioral insights, content strategy and management, digital, interactive and new media services, marketing analytics and research, media planning and buying, medical education, payer marketing and market access, professional advertising and promotion, public affairs and relations, relationship marketing, sales training development, and wellness and consumer advertising and promotion. The network also offers scientific communications and publications planning services through a wholly owned separate legal entity.